<DOC>
	<DOC>NCT00922961</DOC>
	<brief_summary>25 patients, treated by brachytherapy in a phase II study "Mammosite" (from 2003 to 2005), will be asked to attend a clinical exam in order to evaluate the late cutaneous toxicity due to brachytherapy. During this consultation, a blood sample will be taken for analysis ( rate of CD8 T-Lymphocyte Apoptosis)</brief_summary>
	<brief_title>Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer</brief_title>
	<detailed_description>This is an interventional study for the french law</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<criteria>All patient treated by exclusive peroperative brachytherapy in the prior study Mammosite for breast cancer Patient with social security</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>brachytherapy, late cutaneous toxicity</keyword>
</DOC>